Vincerx Stock Quote VINC - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.8768

Bid

0.60

Ask

1.85

Volume

310,181

0.8511 Day's Range 0.935

0.61 52 Week Range 9.3722

Market Cap

406.231M

Previous Close

0.93

Open

0.9272

Last Trade

0.8764

Last Trade Time

Financial Volume

$ 277,203

VWAP

0.893682

Average Volume (3m)

1,271,115

Shares Outstanding

21,380,570

Dividend Yield

PE Ratio

-10.12

Earnings Per Share (EPS)

-1.88

Revenue

Net Profit

-40.16M

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, u... Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform. Show more

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Website

vincerx.com

Headquarters

Wilmington, Delaware, USA

Founded

2021

Vincerx Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VINC. The last closing price for Vincerx was $0.93. Over the last year, Vincerx shares have traded in a share price range of $ 0.61 to $ 9.3722.

Vincerx currently has 21,380,570 shares outstanding. The market capitalization of Vincerx is $406.23 million. Vincerx has a price to earnings ratio (PE ratio) of -10.12.

Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants

PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced the pricing of an underwritten public offering of (i) 6,000,000 shares of its common...

Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants

PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced a proposed underwritten public offering of shares of its common stock and accompanying...

Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024

VIP236 demonstrated positive signs of clinical activity, including tumor reduction, and an improved safety profile in heavily pretreated patients with metastatic solid tumors...

Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...

New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business Network

NEW YORK, Oct. 13, 2023 (GLOBE NEWSWIRE) -- New to The Street, an FMW Media business show production, will air its corporate interviews, episodes 521 and 522, as Sponsored Programming on...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0868	10.9873417722	0.79	0.935	0.6607	664760	0.79295571	CS
4	-5.0432	-85.1891891892	5.92	6.07	0.6607	1681836	1.29289899	CS
12	-0.4732	-35.0518518519	1.35	9.3722	0.6607	1271115	3.06063338	CS
26	-0.0735	-7.73439966326	0.9503	9.3722	0.61	868852	2.4938862	CS
52	-0.6932	-44.152866242	1.57	9.3722	0.61	478339	2.35050025	CS
156	-15.0332	-94.4890006285	15.91	18.4265	0.61	246392	3.61086347	CS
260	-19.2432	-95.6421471173	20.12	26.75	0.61	230115	4.28283813	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BENFBeneficient	$ 6.8001 (254.17%)	31.01M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.18M
SHOTWSafety Shot Inc	$ 0.45 (45.16%)	644
AIPArteris Inc	$ 8.185 (38.03%)	1.11M
RGFReal Good Food Company Inc	$ 0.85 (37.32%)	4.26M
MNDRMobile health Network Solutions	$ 3.33 (-84.91%)	18.76M
NUVOHoldco Nuvo Group DG Ltd	$ 2.00 (-57.54%)	1.04M
SPTSprout Social Inc	$ 28.82 (-40.15%)	13.47M
UNITUniti Group Inc	$ 4.441 (-26.35%)	21.07M
IPDNProfessional Diversity Network Inc	$ 1.29 (-24.12%)	662.59k
AAPLApple Inc	$ 183.38 (5.98%)	163.22M
SQQQProShares UltraPro Short QQQ	$ 11.08 (-5.94%)	154.59M
JAGXJaguar Health Inc	$ 0.3164 (7.91%)	142.47M
NKLANikola Corporation	$ 0.6526 (6.55%)	106.88M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.18M